HomeNewsTrendsHealthAmid fear of new Covid strains, RT-PCR test compulsory for those arriving from 7 more nations

Amid fear of new Covid strains, RT-PCR test compulsory for those arriving from 7 more nations

The seven countries are South Africa, Bangladesh, Botswana, China, Mauritius, New Zealand and Zimbabwe.

September 02, 2021 / 20:03 IST

Amid fear of new COVID-19 strains, RT-PCR test is compulsory for passengers arriving from seven more countries, including South Africa, Bangladesh and China, the Centre said on Thursday.

In a letter to all states and Union territories (UTs), the government said considering reports of new mutations in SARS-CoV-2 and rising number of Variants of Concern (VOCs) and Variants of Interest (Vols) globally, seven countries have been added in the list of countries whose travellers will have to get another RT-PCR test done upon landing at Indian airports apart from the one they need to get before embarking on the flight.

These seven countries are South Africa, Bangladesh, Botswana, China, Mauritius, New Zealand and Zimbabwe.

In earlier guidelines issued in February, passengers from only the United Kingdom, Europe and the Middle East had to get the RT-PCR test done again upon landing at Indian airports.

The Centre also asked states/UTs to ensure strict compliance to these guidelines so that the import of Vols and VoCs to India from other countries may be prevented.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"The states/UTs must also strengthen their Whole Genome Sequencing (WGS) activities being coordinated through the Indian SARS-CoV-2 Consortium on Genomics (INSACOG) network of laboratories, by sending a fixed percentage of samples of positive cases among international travellers for genome sequencing to the respective INSACOG Genome Sequencing Laboratories tagged with them," Union health secretary Rajesh Bhushan said in the letter.

Speaking at a press conference, NITI Aayog member (Health) V K Paul noted that although the risk of mutants will exist, tools of testing, tracking, vaccination, clinical preparedness and COVID appropriate behaviour have to be strongly used.

"The impact of mutants, whether it is about severity of disease or about transmissibility, is something that we understand systematically and INSACOG has huge capacity and it has been strengthened over time and using it we will look after it. The screening of international travellers from a genetic sequencing point of view is one of the most critical protocols and pillars," he said.

ICMR Director General Balram Bhargava said a mutant found in Columbia is presently classified as a mutant of interest.

"We are closely observing it and serious disease or rapid spread of it has not been seen, but with time we will be able to tell more about it," he said.

PTI
first published: Sep 2, 2021 08:03 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347